Employees: 12 (2023.0)Legal category: 5785Size: PMECreation date: 2018-12-07 (7 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: PERTUIS (84120), Vaucluse
PHARMACIE DES CARMES : revenue, balance sheet and financial ratios
PHARMACIE DES CARMES is a French company
founded 7 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in PERTUIS (84120),
this company of category PME
shows in 2023 a revenue of 8.7 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DES CARMES (SIREN 844448548)
Indicator
2024
2023
2022
2021
2020
2019
Revenue
N/C
8 741 327 €
7 689 442 €
6 393 723 €
4 085 787 €
3 092 743 €
Net income
780 117 €
602 940 €
967 141 €
655 832 €
120 925 €
131 978 €
EBITDA
N/C
863 023 €
1 228 424 €
1 021 499 €
287 160 €
248 459 €
Net margin
N/C
6.9%
12.6%
10.3%
3.0%
4.3%
Revenue and income statement
In 2024, PHARMACIE DES CARMES generates positive net income of 780 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2019-2024: 132 k€ -> 780 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
780 117 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 72%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 47%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
71.522%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
47.374%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DES CARMES
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2019
2020
2021
2022
2023
2024
Debt ratio
1002.341
953.553
334.694
139.937
101.352
71.522
Financial autonomy
7.297
8.095
19.247
35.098
40.446
47.374
Repayment capacity
14.842
22.925
5.0
2.871
4.019
None
Cash flow / Revenue
6.157%
4.092%
11.037%
12.808%
7.139%
None%
Sector positioning
Debt ratio
71.522024
2022
2023
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Average-12 pts over 3 years
In 2024, the debt ratio of PHARMACIE DES CARMES (71.52) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
47.37%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Average+13 pts over 3 years
In 2024, the financial autonomy of PHARMACIE DES CARMES (47.4%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
4.02 years2023
2022
2023
Q1: 0.95 years
Med: 3.58 years
Q3: 7.48 years
Average+10 pts over 2 years
In 2023, the repayment capacity of PHARMACIE DES CARMES (4.02) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 247.73. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
247.73
Liquidity indicators evolution PHARMACIE DES CARMES
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2019
2020
2021
2022
2023
2024
Liquidity ratio
103.775
166.559
186.392
224.536
220.329
247.73
Interest coverage
4.44
4.982
1.032
0.843
1.069
None
Sector positioning
Liquidity ratio
247.732024
2022
2023
2024
Q1: 129.46
Med: 182.14
Q3: 260.79
Good+12 pts over 3 years
In 2024, the liquidity ratio of PHARMACIE DES CARMES (247.73) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Interest coverage
1.07x2023
2022
2023
Q1: 0.38x
Med: 2.71x
Q3: 6.47x
Average+6 pts over 2 years
In 2023, the interest coverage of PHARMACIE DES CARMES (1.1x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DES CARMES
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2019
2020
2021
2022
2023
2024
Operating WCR
525 148 €
914 930 €
873 255 €
1 453 920 €
1 833 056 €
0 €
Inventory turnover (days)
68
64
54
58
62
0
Customer payment term (days)
3
3
7
4
4
0
Supplier payment term (days)
69
63
46
47
49
0
Positioning of PHARMACIE DES CARMES in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE DES CARMES is estimated at
10 891 010 €
(range 7 584 327€ - 16 293 574€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
7584k€10891k€16293k€
10 891 010 €Range: 7 584 327€ - 16 293 574€
NAF 5 année 2024
Valuation method used
Net Income Multiple
780 117 €
×
14.0x
=10 891 010 €
Range: 7 584 327€ - 16 293 574€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DES CARMES with other companies in the same sector:
Frequently asked questions about PHARMACIE DES CARMES
What is the revenue of PHARMACIE DES CARMES ?
The revenue of PHARMACIE DES CARMES in 2023 is 8.7 M€.
Is PHARMACIE DES CARMES profitable?
Yes, PHARMACIE DES CARMES generated a net profit of 780 k€ in 2024.
Where is the headquarters of PHARMACIE DES CARMES ?
The headquarters of PHARMACIE DES CARMES is located in PERTUIS (84120), in the department Vaucluse.
Where to find the tax return of PHARMACIE DES CARMES ?
The tax return of PHARMACIE DES CARMES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DES CARMES operate?
PHARMACIE DES CARMES operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart